Mark Christopher Legrand Baylis
Profile
Mark Christopher Legrand Baylis worked as a Director of Quality & Regulatory Affairs at Deltex Medical Group Plc and as a Director at Deltex Medical Ltd.
Former positions of Mark Christopher Legrand Baylis
Companies | Position | End |
---|---|---|
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Director/Board Member | 18/10/2018 |
DELTEX MEDICAL GROUP PLC | General Counsel | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
DELTEX MEDICAL GROUP PLC | Health Technology |
Private companies | 1 |
---|---|
Deltex Medical Ltd.
Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears. | Distribution Services |
- Stock Market
- Insiders
- Mark Christopher Legrand Baylis